AbbVie Inc.
ABBV
$172.99
$1.310.76%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -102.68% | -12.20% | -32.31% | 472.80% | -66.76% |
| Total Depreciation and Amortization | 1.25% | -6.98% | -5.71% | -2.49% | -3.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 279.96% | 13.17% | 45.31% | -86.73% | -27.66% |
| Change in Net Operating Assets | -189.62% | -71.45% | -710.47% | 130.46% | -47.64% |
| Cash from Operations | 48.29% | -28.08% | -64.06% | -3.65% | -36.01% |
| Capital Expenditure | -41.95% | -13.70% | -35.39% | -10.29% | 3.76% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -224.05% | -5,309.55% | -426.88% | -2,559.77% | -84.33% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 597.62% | 6,842.86% | -500.00% | -120.69% | -164.62% |
| Cash from Investing | -134.25% | -2,137.40% | -223.17% | -1,821.44% | -78.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -221.18% | -20,050.00% | -234.13% | -278.09% | 73.81% |
| Issuance of Common Stock | -67.74% | 86.11% | -79.17% | 95.38% | -41.51% |
| Repurchase of Common Stock | -11,833.33% | -325.00% | 10.00% | 32.28% | 25.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.80% | -4.72% | -4.76% | -4.17% | -4.79% |
| Other Financing Activities | 101.75% | 150.00% | 100.00% | 74.14% | 82.52% |
| Cash from Financing | -54.21% | -15.45% | -55.54% | 274.73% | 53.82% |
| Foreign Exchange rate Adjustments | -300.00% | 150.00% | 10.00% | -325.00% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -266.38% | -229.70% | -341.06% | 310.96% | 82.02% |